Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
12/23/2004 | WO2004074310A8 Mycobacterial diagnostics |
12/23/2004 | WO2004072269A3 Bex4 nucleic acids, polypeptides, and method of using |
12/23/2004 | WO2004072229A3 Chemical treatment of biological samples for nucleic acid extraction and kits therefor |
12/23/2004 | WO2004071429A3 Lung inflammation treatment |
12/23/2004 | WO2004016757A3 Methods, compositions and kits for producing nucleic and acid sequences |
12/23/2004 | US20040260080 Solid phase synthesis; conjugation with lanthanide chelates via Mitsunobu alkylation |
12/23/2004 | US20040259829 Carboxylesterase; antitumor agents; drug screening; bioassay |
12/23/2004 | US20040259248 RNA interference mediating small RNA molecules |
12/23/2004 | US20040259247 short interfering RNAs for use treating diseases, in protein separation or purification, in drug screening; cell with target gene-specific knockout phenotype; double stranded RNA; RNA fragments are the sequence-specific mediators of RNAi (RNA interference) |
12/23/2004 | US20040259202 Novel angiogenesis inhibitor |
12/23/2004 | US20040259195 Anti-cellular proliferative disorder polypeptide |
12/23/2004 | US20040259194 Cell line and uses thereof |
12/23/2004 | US20040259163 Antibodies to mammalian adhesion protease peptides |
12/23/2004 | US20040259157 multiple coagulation factor deficiency 2 protein (MCFD2); assays for the detection of MCFD2 and polymorphisms and mutations associated with disease states; diagnosis of factor V and factor VIII deficiency |
12/23/2004 | US20040259148 electrochemiluminescence (ECL) assay apparatus with ECL-inactive electrode surface having a first assay-ligand immobilized thereon and an ECL-active microparticle having a second assay ligand immobilized thereon |
12/23/2004 | US20040259133 precipitation ribonucleic acids by incubating with preservative in an aqueous solutions, then staining and analyzing the cells for messenger ribonucleic acid expression patterns by fluorescence in-situ hybridization |
12/23/2004 | US20040259122 Autocatalysis/yeast two-hybrid assay |
12/23/2004 | US20040259115 amplifying a nucleic acid using two reverse transcriptases that work synergistically under the same buffer conditions to produce more complete cDNAs that are useful for expression profiling; relieve the inhibition of RT PCR (reverse transcriptase polymerase chain reaction) |
12/23/2004 | US20040259114 Coactivators in the diagnosis and treatment of breast cancer |
12/23/2004 | US20040259108 Compositions and methods for detecting west nile virus |
12/23/2004 | US20040259102 Detection of chemical ligation using fluorescence quenching leaving groups |
12/23/2004 | US20040259082 Polymerases with charge-switch activity and methods of generating such polymers |
12/23/2004 | US20040259078 Detection of varicella-zoster virus |
12/23/2004 | US20040258681 Nucleic acid and amino acid sequences; purified antibodies, expression vectors, host cells |
12/23/2004 | US20040258671 Delivering antiinflammatory cytokines to nervous system using gene therapy techniques |
12/23/2004 | US20040258656 Identified via SELEX method; phosphate-containing ligand is conjugated to polyoxyethylene glycol; transforming growth factor (TGF); pharmacokinetics |
12/23/2004 | US20040258616 Compositions and methods for treating cancer using IGSF9 and LIV-1 |
12/23/2004 | DE10324063A1 Preparing nucleotides on controlled pore glass, useful for making libraries for screening to identify aptamers, by coupling protected deoxyphosphoramidite directly to amino groups on the glass |
12/23/2004 | CA2528958A1 Combinatorial nucleobase oligomers comprising universal base analogues and methods for making and using same |
12/23/2004 | CA2528012A1 Methods and compositions for controlling efficacy of rna silencing |
12/23/2004 | CA2527869A1 Method for the treatment of malignancies |
12/23/2004 | CA2526974A1 Proteases |
12/23/2004 | CA2526753A1 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections |
12/23/2004 | CA2521508A1 Methods for identification of coronaviruses |
12/23/2004 | CA2514288A1 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease |
12/22/2004 | EP1489422A2 Multisignal labeling reagents, processes and uses therefor |
12/22/2004 | EP1489171A1 Functional molecule and process for producing the same |
12/22/2004 | EP1488236A2 Arrays of microparticles and methods of preparation thereof |
12/22/2004 | EP1488009A2 Template-driven processes for synthesizing polymers and components related to such processes |
12/22/2004 | EP1487995A2 Protein carrier system for therapeutic oligonucleotides |
12/22/2004 | EP1487992A2 Central airway administration for systemic delivery of therapeutics |
12/22/2004 | EP1487981A2 Growth regulating proteins |
12/22/2004 | EP1487978A2 An improved method for synthesising templated molecules |
12/22/2004 | EP1487973A1 Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents |
12/22/2004 | EP1487867A2 Modified plasminogen activator inhibitor type-1 and methods based thereon |
12/22/2004 | EP1487853A2 Secretion, transcription and sporulation genes in bacillus clausii |
12/22/2004 | EP1487852A1 Anti-protozoal vaccine |
12/22/2004 | EP1487851A2 A building block capable of functional entity transfer to nucleophil |
12/22/2004 | EP1487850A2 A building block forming a c-c or a c-hetero atom bond upon reaction |
12/22/2004 | EP1487849A2 A building block capable of transferring a functional entity |
12/22/2004 | EP1487848A2 A building block forming a c=c double bond upon reaction |
12/22/2004 | EP1487412A1 Chemosensitizing with liposomes containing oligonucleotides |
12/22/2004 | EP1379693A4 Bio-barcodes based on oligonucleotide-modified particles |
12/22/2004 | EP1235840A4 Methods for identifying compounds that affect rna/rna binding protein interactions |
12/22/2004 | EP1226278A4 Methods for identifying and using maintenance genes |
12/22/2004 | EP1196425A4 Detection of giardia |
12/22/2004 | EP1175430A4 Antisense-oligos with better stability and antisense effect |
12/22/2004 | EP0906110B1 Dna vaccine formulations |
12/22/2004 | EP0658200B1 Glucagon receptors |
12/22/2004 | CN1181088C Dinucleotide for treating pulmonary tuberulosis |
12/21/2004 | US6833450 Preparing the arrays using dilute solutions of iodine to oxidize phosphite ester linkages to phosphate ester linkages |
12/21/2004 | US6833447 Myxococcus xanthus genome sequences and uses thereof |
12/21/2004 | US6833440 Membrane protein for use in the diagnosis and treatment of nervous system, psychological, vision and brain disorders |
12/21/2004 | US6833252 A DNA sequence that can be incorporated in cloning and expression vectors, transformed cell lines and transgenic animals; the vectors are useful in gene mapping and site-directed insertion of genes |
12/21/2004 | US6833132 Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method of inhibiting KGF activity |
12/21/2004 | CA2140649C Hybrid oligonucleotide phosphorothioates |
12/16/2004 | WO2004108965A1 Methods and reagents for quantitative analysis of dehalococcoides species |
12/16/2004 | WO2004108945A2 Oligonucleotide modulation of cell adhesion |
12/16/2004 | WO2004108904A2 Porcine cmp-n-acetylneuraminic acid hydroxylase gene |
12/16/2004 | WO2004108895A2 Humanized antibodies that recognize beta amyloid peptide |
12/16/2004 | WO2004108890A2 Dilute methanol -or ethanol- induced production of polypeptides in microorganisms |
12/16/2004 | WO2004108081A2 Oligonucleotide synthesis with alternative solvents |
12/16/2004 | WO2004108079A2 Parkin-interacting proteins |
12/16/2004 | WO2004108071A2 Targeting polypeptides to the central nervous system |
12/16/2004 | WO2004090115A3 Renilla gfp mutants with increased fluorescent intensity and special shift |
12/16/2004 | WO2004081574A3 Detection, monitoring and treatment of cancer |
12/16/2004 | WO2004081520A3 Optically decodable microcarriers, arrays and methods |
12/16/2004 | WO2004072252A3 Polymerase-based protocols for the introduction of deletions and insertions |
12/16/2004 | WO2004072245A3 Polymerase-based protocols for the introductions of deletions and insertions |
12/16/2004 | WO2004042344A3 Fabrication of a high resolution biological molecule detection device with gold electrical conductors |
12/16/2004 | WO2004037907A3 Luminescent metal ion complexes |
12/16/2004 | WO2004000872A9 Improved alphavirus vectors having attenuated virion structural proteins |
12/16/2004 | WO2003092582B1 Chimeric ebola virus envelopes and uses therefor |
12/16/2004 | WO2003087115B1 Oligomeric compounds having modified phosphate groups |
12/16/2004 | WO2003054152A3 Novel nucleic acids and polypeptides |
12/16/2004 | WO2003027254A3 15625 receptor, a novel g-protein coupled receptor |
12/16/2004 | US20040254365 administering a fusion polypeptide including a signal peptide and a part of an envelope protein of the flavivirus; or an expression vector containing a nucleic acid encoding the fusion polypeptide; vaccines |
12/16/2004 | US20040254364 Phage display of a biologically active Bacillus thuringiensis toxin |
12/16/2004 | US20040254363 Genes and snps associated with eating disorders |
12/16/2004 | US20040254361 Gene encoding protein from merozoite of Babesia caballi, recombinant protein obtained with said gene and use thereof |
12/16/2004 | US20040254358 Phosphorous-linked oligomeric compounds and their use in gene modulation |
12/16/2004 | US20040254355 Labeling reagents comprising aphenylic analogs of rhodamine dyes |
12/16/2004 | US20040254098 Therapy, diagnosis, or electronic component |
12/16/2004 | US20040253723 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
12/16/2004 | US20040253693 Methods for the biosynthesis of polyesters |
12/16/2004 | US20040253685 eNOS mutations useful for gene therapy and therapeutic screening |
12/16/2004 | US20040253679 Immunomodulatory agent which binds endothelial growth factor for use as therapeutic agent in treatment of tumors; tissue target therapy |
12/16/2004 | US20040253667 Expression vector comprising nuclelotide sequences coding membrane protein for use in identifying modulator for treatment of cell proliferative, nervous system and inflammatory diseases |
12/16/2004 | US20040253666 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/16/2004 | US20040253663 Genes encoding carotenoid compounds |